ebomi
Colour theme
Sign in
Insider · CIK 0001265094

Couchman Jonathan

CIK 0001265094 Name as filed on the most recent filing

Filed as Couchman Jonathan (20)

90 transaction lines · from 20 filings · filed 2003-09-29 to 2021-08-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2021-08-13 Enzon Pharmaceuticals, Inc.
ENZN 		S, Open-market sale 57,500 disposed 0.39 22,413.50 Form 4, filing 0000921895-21-002138
2021-08-13 Enzon Pharmaceuticals, Inc.
ENZN 		S, Open-market sale 50,000 disposed 0.39 19,490.00 Form 4, filing 0000921895-21-002138
2020-08-25 Enzon Pharmaceuticals, Inc.
ENZN 		S, Open-market sale 25,000 disposed 0.19 4,782.50 Form 4, filing 0000921895-20-002331
2020-08-24 Enzon Pharmaceuticals, Inc.
ENZN 		S, Open-market sale 52,100 disposed 0.18 9,555.14 Form 4, filing 0000921895-20-002331
2020-08-05 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 506,292 acquired 0.20 101,258.40 Form 4, filing 0000921895-20-002115
2020-03-26 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 160,785 acquired 0.14 22,509.90 Form 4, filing 0000921895-20-000958
2020-03-26 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 160,785 acquired 0.14 22,509.90 Form 4, filing 0001193805-20-000418
2020-03-25 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 469,551 acquired 0.14 65,737.14 Form 4, filing 0000921895-20-000958
2020-03-25 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 469,551 acquired 0.14 65,737.14 Form 4, filing 0001193805-20-000418
2020-03-23 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 2,678 acquired 0.14 374.92 Form 4, filing 0000921895-20-000958
2020-03-23 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 2,678 acquired 0.14 374.92 Form 4, filing 0001193805-20-000418
2020-03-13 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 19,709 acquired 0.14 2,660.72 Form 4, filing 0000921895-20-000958
2020-03-13 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 19,709 acquired 0.14 2,660.72 Form 4, filing 0001193805-20-000418
2019-02-11 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 15,500 acquired 0.25 3,875.00 Form 4, filing 0000921895-19-000500
2019-02-11 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 10,000 acquired 0.25 2,500.00 Form 4, filing 0000921895-19-000500
2019-02-11 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 10,000 acquired 0.25 2,500.00 Form 4, filing 0000921895-19-000500
2019-02-11 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 10,000 acquired 0.25 2,500.00 Form 4, filing 0000921895-19-000500
2019-02-11 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 5,000 acquired 0.25 1,250.00 Form 4, filing 0000921895-19-000500
2019-02-11 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 500 acquired 0.25 125.00 Form 4, filing 0000921895-19-000500
2019-01-07 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 2,000 acquired 0.26 510.00 Form 4, filing 0000921895-19-000048
2019-01-04 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 2,500 acquired 0.26 637.50 Form 4, filing 0000921895-19-000048
2019-01-03 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 4,500 acquired 0.26 1,147.50 Form 4, filing 0000921895-19-000048
2018-12-21 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 312,523 acquired 0.27 84,099.94 Form 4, filing 0000921895-19-000048
2018-12-20 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 213,189 acquired 0.24 50,419.20 Form 4, filing 0000921895-19-000048
2018-12-19 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 15,261 acquired 0.23 3,510.03 Form 4, filing 0000921895-19-000048
2018-12-07 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 2,500 acquired 0.22 550.00 Form 4, filing 0000921895-19-000048
2018-12-06 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 1,100 acquired 0.22 242.00 Form 4, filing 0000921895-19-000048
2018-12-04 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 450 acquired 0.22 99.00 Form 4, filing 0000921895-19-000048
2018-12-03 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 42,450 acquired 0.22 9,339.00 Form 4, filing 0000921895-19-000048
2018-11-21 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 40,050 acquired 0.22 8,811.00 Form 4, filing 0000921895-19-000048
2018-11-19 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 15,000 acquired 0.22 3,294.00 Form 4, filing 0000921895-19-000048
2018-11-16 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 2,500 acquired 0.21 525.00 Form 4, filing 0000921895-19-000048
2018-11-15 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 100,000 acquired 0.21 21,000.00 Form 4, filing 0000921895-19-000048
2018-11-12 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 100,000 acquired 0.21 21,000.00 Form 4, filing 0000921895-19-000048
2018-08-20 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 67,200 acquired 0.26 17,472.00 Form 4, filing 0000921895-19-000048
2018-08-16 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 8,800 acquired 0.26 2,277.44 Form 4, filing 0000921895-19-000048
2018-08-15 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 20,600 acquired 0.26 5,253.00 Form 4, filing 0000921895-19-000048
2018-08-14 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 3,671 acquired 0.26 936.10 Form 4, filing 0000921895-19-000047
2018-08-13 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 384,100 acquired 0.26 98,905.75 Form 4, filing 0000921895-19-000047
2018-08-10 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 9,500 acquired 0.26 2,470.00 Form 4, filing 0000921895-19-000047
2018-08-06 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 40,316 acquired 0.26 10,482.16 Form 4, filing 0000921895-19-000047
2018-07-30 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 8,255 acquired 0.26 2,146.30 Form 4, filing 0000921895-19-000047
2018-07-27 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 112 acquired 0.26 29.12 Form 4, filing 0000921895-19-000047
2018-07-26 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 26,655 acquired 0.26 6,930.30 Form 4, filing 0000921895-19-000047
2018-07-24 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 11,368 acquired 0.26 2,955.68 Form 4, filing 0000921895-19-000047
2018-07-20 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 355 acquired 0.26 92.30 Form 4, filing 0000921895-19-000047
2018-07-11 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 635 acquired 0.26 165.10 Form 4, filing 0000921895-19-000047
2018-07-10 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 2,800 acquired 0.26 728.00 Form 4, filing 0000921895-19-000047
2018-07-05 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 21,975 acquired 0.26 5,713.50 Form 4, filing 0000921895-19-000047
2018-07-03 Enzon Pharmaceuticals, Inc.
ENZN 		P, Open-market purchase 20,000 acquired 0.26 5,200.00 Form 4, filing 0000921895-19-000047

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. COUCHMAN JONATHAN, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001265094

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.